The PTTG1-binding factor (PBF/PTTG1IP) regulates p53 activity in thyroid cells.

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• PTTG1-binding factor (PBF/PTTG1IP) is a protooncogene implicated in thyroid biology.
• High PBF expression correlates with poor prognosis in human thyroid cancer.
• The exact role of PBF in thyroid tumorigenesis remains unclear.

Purpose of the Study:

• To investigate the role of PBF in thyroid tumorigenesis.
• To determine if PBF regulates the tumor suppressor p53.
• To elucidate the molecular mechanisms by which PBF influences thyroid cancer progression.

Main Methods:

• Coimmunoprecipitation and proximity-ligation assays to assess PBF-p53 interaction.
• Analysis of p53 transactivation and stability.
• Generation and analysis of a thyroid-specific PBF-overexpressing transgenic mouse model.
• Fluorescent inter simple sequence repeat-PCR for genetic instability assessment.
• Quantitative analysis of DNA repair gene expression and Rad6 levels.

Main Results:

• PBF directly binds to p53 in thyroid cells, repressing its transactivation.
• PBF decreases p53 stability via Mdm2-dependent ubiquitination.
• Thyroid-specific PBF overexpression in mice leads to increased genetic instability.
• PBF overexpression represses key DNA repair genes, including Mgmt, Rad51, and Xrcc3.
• PBF induction up-regulates Rad6 expression in murine thyrocytes, correlating with human thyroid tumors.

Conclusions:

• PBF acts as a novel negative regulator of p53 function in thyroid tumorigenesis.
• PBF contributes to thyroid cancer development by promoting genetic instability and impairing DNA repair.
• These findings offer new insights into the molecular mechanisms driving thyroid cancer, particularly in cases with high PBF and rare p53 mutations.